Sulfhemoglobin

Sulfhemoglobin is a modified form of hemoglobin in which sulfur becomes tightly incorporated into the heme portion of the molecule. This change prevents the affected hemoglobin from carrying oxygen normally and gives blood a characteristic greenish or slate color. The test measures what fraction of your total hemoglobin has been converted to sulfhemoglobin.

It is typically performed on a blood sample using specialized spectrophotometric methods or co-oximetry that can distinguish sulfhemoglobin from other hemoglobin derivatives. The condition is uncommon and is usually linked to exposure to certain drugs or chemicals that supply sulfur or promote sulfur binding to hemoglobin.

Even a modest proportion of sulfhemoglobin can reduce the overall oxygen-carrying capacity of blood and can cause a gray or blue tint to the skin and lips that does not improve with supplemental oxygen. Clinicians consider this test when there is unexplained cyanosis, especially if there is a history of exposure to sulfur-containing medications, hydrogen sulfide, or other relevant chemicals.

Confirming sulfhemoglobin helps your care team identify the source of exposure and guide changes to medications or workplace and environmental safety. Because sulfhemoglobin forms irreversibly in affected red cells, its presence can persist until those cells are naturally replaced, so recognizing the cause is important to prevent ongoing formation.

If your result is higher than expected, it suggests that some of your hemoglobin has been converted to sulfhemoglobin. Your clinician will review your medications, over-the-counter products, and potential environmental or occupational exposures. Do not stop any prescribed medicine without medical advice. If a likely source is found, removing that exposure is the key step; levels then decline as older red cells are replaced.

If symptoms such as shortness of breath, headache, or persistent cyanosis occur, contact your clinician or seek urgent care, since similar symptoms can be caused by other conditions. Follow-up may include repeat testing, checks for other hemoglobin variants such as methemoglobin, and evaluation for coexisting anemia or cardiopulmonary issues. Most cases improve once the source is addressed, and your care team will tailor monitoring and treatment to your situation.